Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
99 hedge funds and large institutions have $101M invested in Enzo Biochem, Inc. in 2016 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 10 closing their positions.
100% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 10
60% more call options, than puts
Call options by funds: $481K | Put options by funds: $300K
21% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 24
11% more funds holding
Funds holding: 89 → 99 (+10)
2% more capital invested
Capital invested by funds: $98.6M → $101M (+$2.16M)
0.56% more ownership
Funds ownership: 47.57% → 48.13% (+0.56%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.47M |
| 2 |
Renaissance Technologies
New York
|
+$876K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$708K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$673K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$541K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$2.48M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$2.27M |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$965K |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$665K |
| 5 |
BCM
Breithorn Capital Management
New York
|
-$633K |
ENZ Hedge Fund Activity: Q1 2016 in Review
99 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q1 2016, worth a combined $101M — up 2.2% from $98.6M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new ENZ positions and 10 closed out — a net gain of 10 holders — while 29 added to existing stakes and 24 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $3.47M. The largest seller was First Light Asset Management, cutting an estimated $2.48M.
- 99 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q1 2016, up from 89 in Q4 2015.
- Funds reported $101M of Enzo Biochem, Inc. stock for Q1 2016, up 2.2% quarter-over-quarter.
- 20 funds opened new Enzo Biochem, Inc. positions in Q1 2016 and 10 closed out, a net change of +10 holders.
- The largest Enzo Biochem, Inc. buyer in Q1 2016 was Acadian Asset Management, an estimated $3.47M added.
- The largest Enzo Biochem, Inc. seller in Q1 2016 was First Light Asset Management, an estimated $2.48M sold.
Based on aggregated 13F filings for Q1 2016.